Earnings Preview For HP

HP (NYSE:HPQ) is set to give its latest quarterly earnings report on Tuesday, 2023-08-29. Here’s what investors need…

HP (NYSE:HPQ) is set to give its latest quarterly earnings report on Tuesday, 2023-08-29. Here’s what investors need to know before the announcement.

Analysts estimate that HP will report an earnings per share (EPS) of $0.86.

HP bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.04, which was followed by a 6.05% drop in the share price the next day.

Here’s a look at HP’s past performance and the resulting price change:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate 0.76 0.74 0.84 1.04
EPS Actual 0.80 0.75 0.85 1.04
Price Change % -6.05% -2.24% 1.8% -7.68%

eps graph

Stock Performance

Shares of HP were trading at $30.84 as of August 25. Over the last 52-week period, shares are up 0.64%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for HP visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Canopy Growth Reports 7% YoY Increase In Q4 Net Revenue, Continues Focus On Innovation In Canada And International Expansion

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Thursday financial results for the fourth quarter and fiscal year ended March 31, 2024.Fourth quarter net revenue for the company's subsidiary Storz & Bickel which manufactures high-end and medically certified cannabis vaporizers surged 43% year-over-year to CA$22million ($16 million).Moreover, Canada's cannabis net revenue in the same period increased 4% year-over-year led by a 16% increase in the Canada medical cannabis business that saw its 5th consecutive quarter of revenue growth.

CGC

Read More

IsoPlexis Announces Preliminary Unaudited Revenue For The Full Year Ended Dec 31, 2022 Total Revenue To Be In The Range Of $16.6M-$16.8M, Down 3%-4% YoY; Q4 Results Were Lower Than Expected Primarily Due To The Timing Of Customer Orders For Instruments

IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended

ISO